Background. The incidence and impact of cytomegalovirus (CMV) disease that occurs
despite CMV prophylaxis among liver transplant recipients have been incompletely defined …

Background. Antiviral prophylaxis has been shown to decrease the incidence of
cytomegalovirus (CMV) disease in organ transplant recipients, but whether CMV disease …

Clinical practice guidelines recommend antiviral prophylaxis to cytomegalovirus (CMV)
donor‐positive/recipient‐negative (D+/R−) liver transplant recipients. We assessed the …

In the era of effective antiviral chemoprophylaxis, cytomegalovirus (CMV) disease has been
inconsistently associated with increased mortality in liver transplant (LT) recipients. A …

The natural history of cytomegalovirus (CMV) disease associated with solid organ
transplantation has been modified as a result of the widespread use of antiviral prophylaxis …

Background. Cytomegalovirus (CMV) D+/R− solid-organ transplant (SOT) recipients carry
increased risk of developing CMV disease; however, other risk factors in these patients have …

We assessed the impact of antiviral prophylaxis and preemptive therapy on the incidence
and outcomes of cytomegalovirus (CMV) disease in a nationwide prospective cohort of solid …

Cytomegalovirus (CMV) is the most common viral pathogen that negatively impacts on the
outcome of liver transplantation. CMV cause febrile illness often accompanied by bone …

Cytomegalovirus (CMV) infection is an opportunistic infection frequently found after solid
organ transplantation, and it contributes significantly to mortality and morbidity. CMV …

Cytomegalovirus (CMV) is a common viral pathogen that influences the outcome of liver
transplantation. In addition to the direct effects of CMV syndrome and tissue-invasive …